Holen Sie sich die Stockscreener-App
487.53
1.05%
-5.19
Vorhandelsmarkt:
487.53
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$492.72
Offen:
$489.31
24-Stunden-Volumen:
1.30M
Relative Volume:
0.52
Marktkapitalisierung:
$184.10B
Einnahmen:
$43.21B
Nettoeinkommen (Verlust:
$6.58B
KGV:
28.20
EPS:
17.29
Netto-Cashflow:
$6.17B
1W Leistung:
-0.19%
1M Leistung:
+5.29%
6M Leistung:
-7.83%
1J Leistung:
-20.74%
1-Tages-Spanne:
$479.03
$492.70
1-Wochen-Bereich:
$479.03
$494.28
52-Wochen-Spanne:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Flow Cytometry Market Insights, Growth Outlook and - GlobeNewswire
What data driven models say about Thermo Fisher Scientific Inc.’s futureJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
Thermo Fisher Scientific concludes acquisition of Sanofi New Jersey site - Medical Dialogues
Thermo Fisher acquires Solventum’s filtration unit for $4B - Modern Healthcare
Thermo Fisher Plummets 1.05% on $630M Trading Volume Ranked 165th as Acquisition Expands U.S. Pharma Manufacturing Footprint - AInvest
Why Thermo Fisher Scientific Stock Tumbled Today - The Motley Fool
Thermo Fisher (TMO) VP Holmes sells $189k in stock - Investing.com
Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site - citybiz
Thermo Fisher Scientific Acquires Solventum’s Purification and Filtration Business For $4 Billion - citybiz
Published on: 2025-09-02 13:48:47 - Newser
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific - MarketScreener
Thermo Fisher Scientific Inc. completed the acquisition of Purification Business of Solventum Corporation for approximately $4 billion. - MarketScreener
Historical volatility pattern of Thermo Fisher Scientific Inc. visualizedWeekly Trade Report & Weekly Breakout Watchlists - Newser
Does Thermo Fisher Scientific Inc. show high probability of reboundBond Market & Safe Capital Investment Plans - Newser
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business - PharmiWeb.com
Thermo Fisher Completes $4 Billion Solventum Acquisition - TipRanks
Thermo Fisher Scientific Acquires NJ Site from Sanofi - Contract Pharma
Solventum completes $4.1B sale of Purification & Filtration business to Thermo Fisher - MassDevice
Solventum Closes Sale of Purification, Filtration Business to Thermo Fisher - MarketScreener
Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield Facility in New Jersey - MarketScreener
Thermo Fisher’s Strategic Acquisition of Sanofi’s Ridgefield Site and Its Impact on Biopharma Manufacturing Growth - AInvest
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - MarketScreener
$4 Billion Deal: Solventum Divests P&F Business to Thermo Fisher, Plans Major Debt Reduction - Stock Titan
Is Thermo Fisher Scientific Inc. stock undervalued right nowGlobal Markets & Trade Opportunity Analysis - خودرو بانک
Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches - Yahoo Finance
Gene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. stock retracement – recovery analysis - Newser
Volume spikes in Thermo Fisher Scientific Inc. stock – what they mean2025 Bull vs Bear & Verified Entry Point Signals - Newser
Can Thermo Fisher Scientific Inc. expand into new marketsMarket Activity Report & Fast Entry Momentum Alerts - خودرو بانک
Is Thermo Fisher Scientific Inc. impacted by rising rates2025 Support & Resistance & Risk Controlled Stock Pick Alerts - خودرو بانک
Thermo Fisher Expands US Base With New Mebane Facility - Healthcare Digital
What’s the analyst consensus on Thermo Fisher Scientific Inc.July 2025 Weekly Recap & Long-Term Safe Return Strategies - خودرو بانک
Should you hold or exit Thermo Fisher Scientific Inc. now2025 EndofYear Setup & Community Consensus Stock Picks - Newser
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Combining machine learning predictions for Thermo Fisher Scientific Inc.Quarterly Portfolio Summary & Target Return Focused Picks - Newser
PFAS Testing Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Danaher Dominate with Advanced Analytical Solutions, Strategic Acquisitions, and Regulatory-Driven Innovations - Yahoo Finance
Does Thermo Fisher Scientific Inc. meet Warren Buffett’s criteria2025 Price Targets & Community Consensus Trade Alerts - خودرو بانک
Is this a good reentry point in Thermo Fisher Scientific Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Comparing Thermo Fisher Scientific Inc. in custom built stock radars2025 Price Targets & High Accuracy Trade Alerts - Newser
Did Thermo Fisher's (TMO) New Carbon Neutral Plant Just Reinforce Its U.S. Supply Chain Advantage? - simplywall.st
Will Thermo Fisher Scientific Inc. outperform the market in YEARWeekly Market Report & Consistent Growth Equity Picks - خودرو بانک
Is Thermo Fisher Scientific Stock Underperforming The Dow? - Barchart.com
Clinical Trial Supplies Company Evaluation Report 2025 | Thermo Fisher Scientific, Sharp Services, and Parexel International Strengthen Global Clinical Trial Supply and CRO Capabilities - Yahoo Finance
Clinical Trials Supplies & Services Company Evaluation Report 2025 | Thermo Fisher Scientific, Sharp Services, and Parexel International Lead with Comprehensive Clinical Trial Supply and CRO Solutions - Yahoo Finance
Central lab Services Clinical Trial Lab Services Company Evaluation Report 2025 | Thermo Fisher Scientific, IQVIA, and ICON Lead - Yahoo Finance
Has Thermo Fisher Scientific Inc. formed a bullish divergenceJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - Newser
What momentum shifts mean for Thermo Fisher Scientific Inc.2025 Short Interest & Accurate Technical Buy Alerts - Newser
Thermo Fisher Scientific Inc. stock daily chart insightsWeekly Trade Report & Risk Controlled Swing Alerts - Newser
Automated trading signals detected on Thermo Fisher Scientific Inc.2025 Fundamental Recap & AI Powered Trade Plan Recommendations - Newser
Can swing trading help recover from Thermo Fisher Scientific Inc. lossesJuly 2025 Catalysts & Capital Efficiency Focused Strategies - Newser
Thermo Scientific Screw Cap Micro Tubes:Tubes:Microtubes | Fisher - michiganreview.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):